LRMR icon

Larimar Therapeutics

116 hedge funds and large institutions have $245M invested in Larimar Therapeutics in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 44 increasing their positions, 32 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

19% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 27

42% less capital invested

Capital invested by funds: $421M → $245M (-$176M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
116
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.13M
Puts
$400K
Net Calls
Net Calls Change

Top Buyers

1 +$3.39M
2 +$1.88M
3 +$1.54M
4
BlackRock
BlackRock
New York
+$1.13M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$1.06M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$82.2M
2
$24.9M
3
$23.4M
4
$18M
5
$16.1M
6
$12.6M
7
$8.49M
8
$8.13M
9
$4.91M
10
$4.02M
11
$3.81M
12
$3.43M
13
$3.26M
14
$2.98M
15
$2.85M
16
$2.41M
17
$1.99M
18
$1.95M
19
$1.76M
20
$1.46M
21
$1.44M
22
$987K
23
$905K
24
$851K
25
$730K